Clinical trial
Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate…
NCT00002721 · University of New Mexico, Other · Completed
Key facts
| NCT number | NCT00002721 |
|---|---|
| Title | Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer |
| Official title | A PHASE I TRIAL OF ESTRAMUSTINE PHOSPHATE AND DOXORUBICIN IN HORMONE REFRACTORY METASTATIC PROSTATE CANCER |
| Lead sponsor | University of New Mexico, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Procedure |
| Interventions | doxorubicin hydrochloride, estramustine phosphate sodium, drug resistance inhibition treatment |
| Enrollment | 18 |
| Start date | Mar 1, 1995 |
| Primary completion | Jun 1, 2013 |
| Completion | Jun 1, 2013 |
| First posted | May 26, 2004 |
| Last update posted | May 21, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: